| Literature DB >> 33628135 |
Marianna Diomidous1, Marianna Isaakidou1.
Abstract
INTRODUCTION: Vaccination is the best method for microbial and viral infections prevention. Especially for health professionals, flu vaccination is the best method to protect them, and the same applies for the patients and the general population from being infected. One of the most important preventive measure is vaccination and the main types of vaccines available, the limitations and side effects are briefly presented. AIM: The aim of this paper is to present the necessity of the healthcare professionals to conceptualize the importance of flu vaccination ifor themselves and the general population. Healthcare professionals are influenced by their knowledge, attitudes, and beliefs. Epidemiological surveys on this issue are presented for Greece, European Union, and the USA.Entities:
Keywords: Flu Vaccination; Healthcare Facilities; Healthcare Professionals; Types of Vaccines
Year: 2020 PMID: 33628135 PMCID: PMC7879438 DOI: 10.5455/msm.2020.32.307-314
Source DB: PubMed Journal: Mater Sociomed ISSN: 1512-7680
Figure 1.Number of cases in ICU per week in patients with positively diagnosed influenza. Total number of cases in Greece per week 40/2018 till week 20/2019 (13–19 May 2019). Total number of declared cases until the week 20/2019: 374 (6).
Vaccination coverage rates of GPs: in total, by sector and by age group (17).
| Influenza | ||
|---|---|---|
| Season 2018-2019 | Season 2017-2018 | |
| Total | 57% | 56% |
| By sector: | ||
| Public Sector | 56% | 56.2% |
| Private Sector | 55% | 55.4% |
| By age group (years): | ||
| 30-39 | 35% | 30% |
| 40-49 | 52% | 53% |
| 50-59 | 66% | 68% |
| >=60 | 74% | 68% |
Flu vaccination in USA for the seasonal influenza (6).
| Trade Name (Manufacturer) | Presentation | Age Indication |
|---|---|---|
| IIV4 – Standard Dose – Egg based | ||
| Afluria Quadrivalent (Seqirus) | 0.25mL PFS | 6 through 35 mos |
| Fluarix Quadrivalent (GlaxoSmithKline) | 0.5mL PFS | ≥ 6 mos |
| FluLaval Quadrivalent (GlaxoSmithKline) | 0.5mL PFS | ≥ 6 mos |
| Fluzone Quadrivalent (Sanofi Pasteur) | 0.25mL PFS | 6 through 35 mos |
| IIV4 – Standard Dose – Cell culture based (ccIIV4) | ||
| Flucelvax Quadrivalent (Seqirus) | 0.5mL PFS | ≥ 4 yrs |
| IIV3 – High Dose – Egg based (HD-IIV3) | ||
| Fluzone High Dose (Sanofi Pasteur) | 0.5mL PFS | ≥ 65 yrs |
| IIV3 – Standard Dose – Egg based with MF59 adjuvant (aIIV3) | ||
| Fluad (Seqirus) | 0.5mL PFS | ≥ 65 yrs |
| RIV4 – Recombinant (HA) | ||
| Flublok Quadrivalent (Sanofi Pasteur) | 0.5mL PFS | ≥ 18 yrs |
| LAIV4 – Egg based | ||
| FluMist Quadrivalent (AstraZeneca) | 0.2 mL | 2 through 49 yrs |
Reasons for refusing influenza vaccination among HCPs (18).
| Reason | Reporting Rate (%) |
|---|---|
| Not informed about the influenza vaccination program | 6.54% |
| Absence during the influenza vaccination program | 7% |
| Belief that they are at no risk for contracting influenza | 44.5% |
| Belief that the vaccine is not effective | 20.79% |
| Fear of vaccine adverse effects | 20.33% |
| Ignorance that HCPs constitute a target group for influenza vaccination | 0.82% |
Figure 2.Average number of percentage (%) of vaccinated healthcare professionals in comparison with the totality of healthcare personnel working in Hospitals and Primary Healthcare Centers in the last two periods of influenza in Greece, time periods 2018-2019 and 2019-2020 (6, 21).
Figure 3.Average number of percentage (%) of vaccinated healthcare personnel in high risk departments in Hospitals in Greece, time period 2019-2020 (21).
Percentage of implementation (%) of strategic actions aiming at improving the vaccination policy in 266 institutions providing healthcare services in Greece (6).
| Strategic Actions | Percentage of Implementation |
|---|---|
| Vaccination at the workplace | 86.1% |
| Free vaccination | 80.4% |
| Organisation of actions for the promotion of vaccination | 77.8% |
| Discussions for the influenza and the flu vaccination | 37.6% |
| Mobile Units used for vaccination | 31.6% |
| Written declaration for refusing vaccination | 54.5% |
| Use of communication media for reminding vaccination | 50.4% |
| Rewarding programs for vaccinated healthcare personnel | 15% |
| Vaccination of chief medical and nursing staff/personnel | 66.9% |
| Support of the vaccination from the central administration of the hospital | 49.6% |
| Leaders vaccination | 35.7% |
| Promotion of the responsibility and safety sensation in the workplace | 63.9% |
| Verbal briefing from the responsible directors of clinics and other sections and laboratories regarding vaccination | 80.8% |